TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation

Xiaoxiao Ma1, Xiaomin Ma1, Yumin Qiu1

  • 1Department of Immunology, Shandong Provincial Key Laboratory of Infection & Immunology, Shandong University School of Basic Medical Sciences, 250012, Jinan, China.

Insights

Tripartite motif-containing 50 (TRIM50) acts as a tumor suppressor in hepatocellular carcinoma (HCC). TRIM50 targets SNAIL, reversing epithelial-to-mesenchymal transition (EMT) and inhibiting cancer progression, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tripartite motif-containing 50 (TRIM50) is part of the tripartite motif (TRIM) protein family, implicated in various cancers.
  • The specific role of TRIM50 in hepatocellular carcinoma (HCC) pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of TRIM50 in hepatocellular carcinoma (HCC).
  • To explore the molecular mechanisms underlying TRIM50's function in HCC, particularly its interaction with SNAIL and its effect on epithelial-to-mesenchymal transition (EMT).

Main Methods:

  • Quantitative analysis of TRIM50 expression in HCC tissues versus non-cancerous tissues.
  • Gain-of-function (overexpression) and loss-of-function (knockdown) assays in HCC cell lines to assess cellular behaviors (proliferation, colony formation, migration, invasion).
  • Biochemical assays to determine TRIM50's direct binding with SNAIL and its effect on SNAIL ubiquitination and degradation.
  • In vivo xenograft tumor models to evaluate the antitumor effect of TRIM50 in HCC.

Main Results:

  • TRIM50 expression is significantly decreased in HCC tissues and correlates with advanced disease progression.
  • Overexpression of TRIM50 inhibits HCC cell proliferation, colony formation, migration, and invasion, while knockdown enhances these malignant behaviors.
  • TRIM50 directly binds to SNAIL, inducing its K-48 linked poly-ubiquitous degradation, thereby reversing SNAIL-mediated EMT.
  • In vivo studies confirm the tumor-suppressive role of TRIM50 in HCC.

Conclusions:

  • TRIM50 functions as a tumor suppressor in HCC by targeting SNAIL for degradation and inhibiting EMT.
  • TRIM50's tumor-suppressive activity suggests its potential as a novel therapeutic target for HCC, especially in cases with SNAIL overexpression.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.2K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.5K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K